Three new members have been appointed to the National Advisory Council for Biomedical Imaging and Bioengineering (NACBIB) of the National Institute of Biomedical Imaging and Bioengineering (NIBIB).
The NACBIB meets three times per year to advise on policy and program priorities related to the conduct and support of research, training, health information dissemination, and other programs that address biomedical imaging, biomedical engineering, and associated technologies and modalities with biomedical applications. The NACBIB also provides second-level review for all applications for funding of research and training grants and cooperative agreements by the NIBIB.
NIBIB Director Roderic I. Pettigrew, Ph.D., M.D., welcomed the following new members at the NACBIB Council meeting on Sept 16, 2014:
Karen Hirschi, Ph.D., is a Professor of Medicine in the Yale Cardiovascular Research Center and the Yale Stem Cell Center in the Department of Medicine at Yale University School of Medicine in New Haven, Connecticut. Dr. Hirschi is an expert in blood vessel formation and is currently studying the potential of adult and embryonic stem and progenitor cells to contribute to neovascularization in response to tissue injury and growth. Dr. Hirschi’s primary research interest is to understand, at the cellular and molecular level, the events leading to blood vessel formation. Her laboratory is specifically interested in the regulation of vascular cell commitment, differentiation and cell cycle progression, and defining signaling pathways that modulate these processes. She has published numerous articles about vascular development and gene therapy in leading medical publications. Dr. Hirschi is the Co-founder and Deputy Director of the Stem Cells and Regenerative Medicine Center at the Baylor College of Medicine. She is a recipient of the Kingsley Award in Medical Research at Yale University and has served as the Elected President of the North American Vascular Biology Organization. Dr. Hirschi is a University Scholar at Pennsylvania State University, and completed her Ph.D. degree in Nutritional Biochemistry at the University of Arizona. She received postdoctoral training at Harvard Medical School, in the Laboratory for Surgical Research directed by Dr. Judah Folkman, where she studied blood vessel development.
A. Gregory Sorensen, M.D., is the President and Chief Executive Officer of Siemens Healthcare in North America, charged with leading the USA organization and providing additional oversight for Canada and Latin America. Dr. Sorensen brings to his leadership position a deep understanding of technology, the biological basis of disease, the importance of measurable outcomes, and the environment of clinical practice. Leading up to his appointment with Siemens, Dr. Sorensen was a practicing neuroradiologist and active researcher with significant experience in clinical care, clinical trials, and translational research. His research and techniques are utilized by scores of centers throughout the world in phase II and III trials in cancer, stroke, and other illnesses. He is a Scholar Awardee of the Radiological Society of America and recipient of the Cornelius G. Dyke Memorial Award from the American Society of Neuroradiology. Previously, Dr. Sorensen served as Professor of Radiology and Health Sciences and Technology at Harvard Medical School; faculty member of the Harvard-MIT Division of Health Sciences and Technology; and Co-Director of the A.A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital, as well as a visiting professor of neuroradiology at Oxford University. Dr. Sorensen holds a B.S. in Biology from California Institute of Technology, a M.S. in Computer Science from Brigham Young University, and a Medical Degree from Harvard Medical School.
Daniel C. Sullivan, M.D., is a professor in the Department of Radiology at Duke University Medical Center and serves as Science Advisor for the Radiological Society of North America (RSNA). At RSNA he leads a national program in quantitative imaging and imaging biomarkers. His areas of clinical and research expertise are in nuclear medicine and oncologic imaging. From 1997 to 2007 Dr. Sullivan was Associate Director in the Division of Cancer Treatment and Diagnosis at the National Cancer Institute (NCI), and also head of the Cancer Imaging Program at NCI. Dr. Sullivan's current responsibilities at Duke include leading the Imaging Core of Duke's Clinical and Translational Science Awards program and the Imaging Program in Development for the Duke Comprehensive Cancer Center. He is a Fellow of the American College of Radiology, Society for Breast Imaging, and the American Institute for Medical and Biological Engineering. He is a recipient of the NIH Award of Merit as well as the NIH Director’s Award for Extraordinary Leadership. Dr. Sullivan’s postgraduate training and academic career include numerous distinctive positions and directorships from 1970 to the present at Bethesda Naval Hospital, Yale-New Haven Hospital, Duke University Medical Center, and the University of Pennsylvania Medical Center. He is a graduate of Brown University and received his M.D. at the University of Vermont Medical College.
About the National Institute of Biomedical Imaging and Bioengineering (NIBIB): The NIBIB’s mission is to support multidisciplinary research and research training at the crossroads of engineering and the biological and physical sciences. NIBIB supports emerging technology research and development within its internal laboratories and through grants, collaborations, and training. More information is available at the NIBIB website.
About the National Institutes of Health (NIH): The NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. More information is available at the NIH website.